1-Oxo-2,3-dihydro-1H-indene-4-carbonitrile

1. STRUCTURE
1-Oxo-2,3-dihydro-1H-indene-4-carbonitrile
2. PRODUCT NAME & DETAILS
Product Name 1-Oxo-2,3-dihydro-1H-indene-4-carbonitrile
Product Code 011432
CAS No 60899-34-5
HS Code 2926.90.00
Molecular Formula C10H7NO
Molecular Wt. 157.17
3. REGULATORY INFORMATION
Chemical nameCommon names and synonymsCAS numberEC number
1-Oxo-2,3-dihydro-1H-indene
-4-carbonitrile
2,3-Dihydro-1-oxo-1H-indene-4-carbonitrile,
4-Cyano-1-indanone
60899-34-5
813-647-6
European Inventory of Existing Commercial Chemical Substances (EINECS)
Not Listed
EC Inventory
Listed
United States Toxic Substances Control Act (TSCA) Inventory
Not Listed
China Catalog of Hazardous chemicals 2015
Not Listed
Chinese Chemical Inventory of Existing Chemical Substances (China IECSC)
Not Listed
Korea Existing Chemicals List (KECL)
Not Listed
Canadian Domestic Substance List (DSL)
Not Listed
Canadian Non-Domestic Substance List (NDSL)
Not Listed
Japanese Existing and New Chemical Substances Inventory (ENCS)
Not Listed


4. SPECIFICATION
Physical Appearance
Light Yellow Solid
Identification (HPLC)
Identical
Purity (HPLC)
NLT 98%
Melting Point
116-117 °C
5. APPLICATION1-Oxo-2,3-dihydro-1H-indene-4-carbonitrile is an organic chemical compound  that is used as a reagent in the Friedel–Crafts acylation of chiral chlorides.

1-Oxo-2,3-dihydro-1H-indene-4-carbonitrile is key intermediate of Ozanimod. Ozanimod is a sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD) API- Ozanimod.
6. HAZARD CLASSIFICATION
Non Hazardous substance.

Irritant

           

  

7. ANNUAL CAPACITY
50 MT.
8. STORAGE CONDITION
Store at ambient temperature in dry place away from direct sun light.
9. PACKING DETAILS

25kg corrugated box pallet.

10. SHELF LIFE
3 years.
Disclaimer
Typical properties should not be considered as specification.
Product covered by valid patents are not offered or supplied for commercial use. The Patent position should be verified by the customer.
Products will not be supplied to countries where they could be in conflict with existing patents.
Products currently covered by valid US patents are offered for R&D use in accordance with 35 USC 271 (e) (I) Above information is given in good faith and without warrenty.

The above information is given in good faith and is without warranty